At Akretiv Animal Health, we are redefining innovation in the animal health industry by leveraging advancements in human medicine to improve the lives of pets. Our unique expertise spans both human and animal health, allowing us to bridge the gap between these sectors. Through collaborative partnerships with life sciences companies, we adapt human health assets for animal use, addressing unmet medical needs in a market that lags 10 to 15 years behind human health innovation.

Our business model is designed to benefit our partners and investors by providing a de-risked pathway to the $50B+ animal health market. We handle the complexities of clinical studies, regulatory filings, and commercialization, allowing our partners to retain control over their intellectual property without diverting resources or budgets from their core programs. At Akretiv, we’re not just advancing animal health — we’re creating a future where pets receive the same level of care and innovation as their human counterparts.